Stay updated on Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma
Sign up to get notified when there's something new on the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page.

Latest updates to the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 to the site; removed the previous note about government funding lapse and operating status (revision v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedSite-wide notice about a lapse in government funding and NIH operation status was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedCosmetic/UI updates include a new 'Show glossary' option, capitalization tweaks (Last Update Submitted that Met QC Criteria; No FEAR Act Data), and a revision tag (v3.4.0). These edits do not alter study data, eligibility or results, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 has been added and Revision: v3.3.3 has been removed. This update does not modify study details or user-facing information.SummaryDifference0.0%

- Check63 days agoChange DetectedA consolidated Locations section has been added listing study sites by state (Illinois, Iowa, Michigan, Minnesota, Nebraska, New Jersey, Pennsylvania) and the page revision updated to v3.3.3.SummaryDifference0.7%

- Check92 days agoChange DetectedPublications section text updated to indicate auto-fill from PubMed, with revision numbers updated to v3.3.2 (additions) and v3.2.0 (deletions).SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page.